About Us
OMass Therapeutics is a biotechnology company focused on developing innovative therapeutics for rare diseases and immunological conditions. The company leverages its proprietary OdyssION™ technology platform to discover and develop small molecule drugs that target membrane proteins, which are often challenging to address with traditional drug discovery methods.
OMass Therapeutics is committed to sustainability and responsible business practices. However, specific details about their sustainability initiatives, such as ESG reports or carbon footprint calculations, are not readily available. The company may be in the early stages of developing comprehensive sustainability strategies or may not publicly disclose detailed sustainability metrics at this time.